Cellectar Biosciences (CLRB) Reports Q1 Loss of $0.30/Share

Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of ($0.30), versus ($1.03) reported last year.

For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Movano (MOVE) Misses Q2 EPS by 195c